MedTrace Logo

Don't Treat Ghosts Anti-MRSA Antibiotics in Osteomyelitis Without Identified MRSA

NCT06096012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2023-10-23

No results posted yet for this study

Summary

Osteomyelitis is described as infection and inflammation of the long bone or bone marrow, often due to an open wound, operation, or invasive trauma.1 It is invasive and involves hematogenous seeding or contiguous spread of the infectious organism

Conditions

  • Osteomyelitis

Interventions

DRUG

Anti-MRSA therapy

chart review to determine the clinical outcomes of patients with osteomyelitis who were placed on definitive anti-MRSA treatment, despite no identified MRSA cultures.

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Matthew Crotty, PharmD · The Methodist Hospital Research Institute

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-23
Primary Completion
2024-06-23
Completion
2024-06-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096012 on ClinicalTrials.gov